Tumor recurrence risk following different COS regimens in infertile women with borderline ovarian tumors: impact on IVF outcomes.

J Ovarian Res · 2025 · PMC12613368 · PMID 41225676

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

Moreover, there was an increasing trend for recurrence in the agonist/antagonist cycle group compared with the mild stimulation group (24.3% vs. 16.7%), which was similar to the recurrence rate of BOTs after FSS reported in previous literature [ 3 , 19 ].

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.